Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 22 clinical trials
Featured trial
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

The purpose of this study is to find out how well ABBV-951 works to control Parkinson's disease symptoms compared to oral Carbidopa (CD)/Levodopa (LD). The study is also

carbidopa
levodopa
  • 102 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations

To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) extended-release capsules (IPX203 ER CD-LD) in comparison to immediate release (IR) CD-LD in the

illicit drug
  • 55 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy and Safety of Gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) to Immediate Release CD/LD in Fluctuating Parkinson’s Disease Patients

A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy and Safety of Gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa

  • 342 views
  • 08 Nov, 2020
  • 1 location
Featured trial
An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.

An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.

  • 895 views
  • 08 Nov, 2020
  • 2 locations
None
Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)

/DDCI in adult patients with Parkinson's disease and end-of-dose motor fluctuations who cannot be stabilized on those combinations. Carbidopa and benserazide are both DDCIs used in association with L

  • 0 views
  • 04 Aug, 2021
  • 1 location
None
Enhancement of Stroke Rehabilitation With Levodopa

Trial investigates the benefits and harms of Levodopa /Carbidopa 100/25mg compared to placebo (given in addition to standardized rehabilitation based on the principles of motor learning) and

  • 2 views
  • 24 Feb, 2021
  • 26 locations
None
Effects of Cannabidiol (CBD) on the Brain

Cannabidiol (CBD) is a phytocannabinoid that is one of 113 identified cannabinoids in the cannabis plant. It is derived from the hemp plant, and may treat conditions like pain, insomnia, and anxiety. CBD is a critical component of medical marijuana and does not cause the "high" typically associated with cannabis. …

  • 26 views
  • 01 Oct, 2021
  • 1 location
None
Synthetic CBD as a Therapy for COVID-19

The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compared to placebo.

  • 0 views
  • 07 Oct, 2021
  • 1 location
None
CBD-Microglia PET Study

This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.

  • 0 views
  • 18 Sep, 2021
  • 1 location
None
Topical CBD in Joint Arthritis

Rationale: CBD is commonly being used as an over-the-counter treatment for arthritis-related pain, however no clinical trial has been performed to establish efficacy. Hypothesis: CBD is more effective than placebo for relieving pain and improving patient-reported outcomes for thumb basal joint arthritis. Study Design: The study design with be a …

  • 0 views
  • 26 Jan, 2021
  • 1 location